Ellevest, Inc. Portage Biotech Inc. Transaction History
Ellevest, Inc.
- $1.66 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding PRTG
# of Institutions
24Shares Held
1.96MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.5MShares$10.4 Million0.0% of portfolio
-
Bison Wealth, LLC213KShares$1.48 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny75.8KShares$525,2940.0% of portfolio
-
Peak6 Investments LLC Chicago, IL55.3KShares$382,9720.0% of portfolio
-
Jane Street Group, LLC New York, NY41.4KShares$287,0050.0% of portfolio
About PORTAGE BIOTECH INC.
- Ticker PRTG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,943,700
- Market Cap $117M
- Description
- Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...